Unadjusted | Adjusted | |||
---|---|---|---|---|
Factor (reference) | OR (95% CI) | p | OR (95% CI) | p |
Female sex (Male) | 0.89 (0.59–1.36) | 0.597 | 0.86 (0.55–1.35) | 0.525 |
Age (continuous) | 1.02 (1.01–1.04) | 0.004 | 0.99 (0.97–1.02) | 0.647 |
BMI (continuous) | 0.98 (0.94–1.02) | 0.390 | 0.97 (0.93–1.02) | 0.249 |
ASA 2 (ASA1) | 1.44 (0.82–2.56) | 0.208 | 1.42 (0.73–2.75) | 0.300 |
ASA3 | 3.16 (1.72–5.82) | < 0.001 | 2.51 (1.11–5.68) | 0.027 |
ASA 4 | 0.01 (0–2 × 1017) | 0.842 | 0.01 (0–1 × 1017) | 0.833 |
CCI (continuous) | 1.24 (1.12–1.38) | < 0.001 | 1.16 (0.94–1.42) | 0.164 |
Vascular disease (No) | 2.08 (1.34–3.23) | 0.001 | ||
Diabetes (No) | 1.14 (0.59–2.19) | 0.704 | ||
Pulmonary disease (No) | 1.03 (0.54–1.97) | 0.937 | ||
Other comorbidities (No) | 2.38 (1.29–4.41) | 0.006 | ||
Bleeding risk (No) | 2.44 (1.17–5.10) | 0.018 | ||
Cholecystitis grade 2–3 (Grade 1) | 1.39 (0.91–2.13) | 0.126 | 1.47 (0.88–2.45) | 0.140 |
Current smoker (Not smoker) | 0.71 (0.32–1.61) | 0.417 | 0.75 (0.33–1.73) | 0.502 |
Time from symptoms to surgery (continuous) | 1.03 (0.97–1.11) | 0.321 | 1 (0.93–1.09) | 0.910 |